Table 4.
Ranks | Age group 26–50 | Age group 51–70 | Age group 71–90 | |||
---|---|---|---|---|---|---|
Feature names | Concordance index changed (median) | Feature names | Concordance index changed (median) | Feature names | Concordance index changed (median) | |
1 | PR status | –0.0247 | ER status | –0.0807 | Module 11 | –0.0323 |
2 | Module 1 | 0 | Module 13 | −0.0221 | Module 1 | –0.0233 |
3 | Module 2 | 0 | Module 4 | −0.0185 | Module 29 | –0.0233 |
4 | Module 3 | 0 | Module 5 | −0.0150 | Module 35 | –0.0233 |
5 | Module 4 | 0 | Diagnosis age | −0.0150 | Module 4 | –0.0222 |
Experiments performed separately with three age groups: 26–50 group; 51–70 group; 71–90 group, with integrating all omics data (integration of mRNA, miRNA, CNB, TMB, diagnosis age, ER status, PR status). Detailed feature rankings are in Figures S5–S7. The bold values are of our interests and are being discussed.